Protective immunity against Naegleria fowleri infection on mice immunized with the rNfa1 protein using mucosal

Jinyoung Lee1, Jong-Kyun Yoo, Hae-Jin Sohn

  • 1Department of Microbiology, Ajou University School of Medicine, Suwon, 443-721, Republic of Korea.

Parasitology Research
|January 22, 2015
PubMed

Insights

Naegleria fowleri infection causes fatal primary amoebic meningoencephalitis (PAM). Immunizing mice with the Nfa1 protein, enhanced by CTB or LTB adjuvants, significantly improved survival rates and induced protective immunity against PAM.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Microbiology

Background:

  • Naegleria fowleri is a free-living amoeba causing fatal primary amoebic meningoencephalitis (PAM).
  • Amoebic adherence to host cells is critical for N. fowleri pathogenicity.
  • The Nfa1 protein, previously identified, is implicated in N. fowleri's contact-dependent pathogenicity.

Purpose of the Study:

  • To evaluate the protective immunity induced by the Nfa1 protein against N. fowleri infection.
  • To assess the adjuvant effects of cholera toxin B subunit (CTB) and E. coli heat-labile enterotoxin B subunit (LTB) on Nfa1-induced immunity.

Main Methods:

  • BALB/c mice were intranasally immunized with Nfa1 protein combined with CTB or LTB adjuvants.
  • Immunized mice were subsequently infected with N. fowleri trophozoites to induce PAM.
  • Survival rates, mean time to death, and serum IgG levels were analyzed.

Main Results:

  • Immunization with Nfa1 plus CTB or LTB significantly prolonged the mean time to death in mice infected with N. fowleri.
  • Mice immunized with Nfa1 plus CTB exhibited a 100% survival rate during the experimental period.
  • Serum IgG levels were significantly elevated in mice receiving Nfa1 with either CTB or LTB adjuvant.

Conclusions:

  • The Nfa1 protein, when administered with CTB or LTB adjuvants, effectively induces protective immunity against Naegleria fowleri infection.
  • CTB and LTB act as potent mucosal adjuvants, enhancing the immunogenicity of the Nfa1 protein for PAM prevention.

Related Concept Videos